🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT03356392
Recruiting Observational

German Stroke Registry - Endovascular Treatment

NCT03356392 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2015-06
Last updated
2024-12-11

Condition(s) studied

Acute Ischemic Stroke

Investigational drug(s) / intervention(s)

telephone call d90

telephone call d90: telephone call on day 90 to assess the primary outcome (mRs d90)

Study summary

The German Stroke Registry (GSR) Endovascular Treatment is an academic, independent, prospective, multicentre, observational registry study. Consecutive patients treated with endovascular stroke treatment will be enrolled in German stroke centers. Patients receive regular care and data will be collected as part of clinical routine. Baseline clinical and procedural information as well clinical follow-up information during in-hospital stay, and up to 90 days of stroke onset are collected. Data collected include demographics, National Institute of Health Stroke Scale (NIHSS) on admission, pre-treatment ASPECTS, information on timing and success of interventional treatment, procedural complications, intracranial hemorrhage, and functional outcome.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Clinical diagnosis of acute ischemic stroke * Eligible for intravenous thrombolysis (IVT) and IVT initiated within 4.5 hours after stroke onset * Confirmed diagnosis of persistent occlusion of terminal carotid artery, middle cerebral artery (M1 or M2), or basilar artery consistent with symptoms * Age \>18 years * Ethic approval in process Exclusion Criteria: none

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Medical Center Hamburg-Eppendorf (UKE) Hamburg Free and Hanseatic City of Hamburg Recruiting

More Universitätsklinikum Hamburg-Eppendorf trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03356392 on ClinicalTrials.gov ↗ ← All trials in Germany